Drugmakers under fire over off-label marketing
FBN’s Liz MacDonald says Public Citizen is urging the FDA to pull ads for five type-2 diabetes drugs over unapproved claims and off-label marketing.
Advertisement
Recommended Stories
Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Motley Fool•Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
The $50 million purchase could turn into Nvidia's biggest investment.
Motley Fool•Trump to set interest rates himself under secret presidential plan
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The Telegraph•Fed's Powell, jobs report and Apple will rock markets this week
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
TheStreet•Generative AI Software Sales Could Soar 6,260%: My Pick for the Best AI Stock to Buy Now (Hint: Not Nvidia)
This little-known software stock could soar as businesses spend more on generative artificial intelligence.
Motley Fool•2 Incredibly Cheap Dividend Stocks to Buy Now
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
Motley Fool•California Fast-Food Chains Are Now Serving Sticker Shock
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
The Wall Street Journal•My late aunt gave her husband a life tenancy in her home — but her attorney won’t even let us see the will. Is this a bad sign?
“When she died, we were told by her attorney that we were responsible for the taxes and property insurance during the time when the life tennant lives in the home.”
MarketWatch•In 4 Days, Philip Morris Stock Becomes an Even Better Investment
The tobacco giant will soon be allowed to sell a proven product in a proven market.
Motley Fool•It’s time to talk about the ‘dirty word’ on Wall Street as ‘whiffs of stagflation’ intrude on markets, chief strategist says
"And that's why it was kind of shocking to see bond yields rise on a day where GDP was a big miss."
Fortune•